Metal complex interactions with DNA

被引:385
作者
Pages, Benjamin J. [1 ]
Ang, Dale L. [1 ]
Wright, Elis P. [2 ]
Aldrich-Wright, Janice R. [1 ,2 ]
机构
[1] Univ Western Sydney, Sch Sci & Hlth, Nanoscale Org & Dynam Grp, Penrith, NSW 2751, Australia
[2] Univ Western Sydney, Sch Med, Penrith, NSW 2751, Australia
关键词
RUTHENIUM(II) ARENE COMPLEXES; POLYNUCLEAR PLATINUM COMPLEXES; INTRASTRAND CROSS-LINK; NUCLEIC-ACID STRUCTURE; L1210 MURINE LEUKEMIA; MAJOR-GROOVE BINDING; CALF THYMUS DNA; ANTITUMOR-ACTIVITY; ANTICANCER COMPLEXES; CRYSTAL-STRUCTURE;
D O I
10.1039/c4dt02700k
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Increasing numbers of DNA structures are being revealed using biophysical, spectroscopic and genomic methods. The diversity of transition metal complexes is also growing, as the unique contributions that transition metals bring to the overall structure of metal complexes depend on the various coordination numbers, geometries, physiologically relevant redox potentials, as well as kinetic and thermodynamic characteristics. The vast range of ligands that can be utilised must also be considered. Given this diversity, a variety of biological interactions is not unexpected. Specifically, interactions with negatively-charged DNA can arise due to covalent/coordinate or subtle non-coordinate interactions such as electrostatic attraction, groove binding and intercalation as well as combinations of all of these modes. The potential of metal complexes as therapeutic agents is but one aspect of their utility. Complexes, both new and old, are currently being utilised in conjunction with spectroscopic and biological techniques to probe the interactions of DNA and its many structural forms. Here we present a review of metal complex-DNA interactions in which several binding modes and DNA structural forms are explored.
引用
收藏
页码:3505 / 3526
页数:22
相关论文
共 304 条
[1]   Optimization of the auxiliary ligand shell of cobalt(III)(8-hydroxyquinoline) complexes as model hypoxia-selective radiation-activated prodrugs [J].
Ahn, GO ;
Ware, DC ;
Denny, WA ;
Wilson, WR .
RADIATION RESEARCH, 2004, 162 (03) :315-325
[2]   In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer [J].
Aird, RE ;
Cummings, J ;
Ritchie, AA ;
Muir, M ;
Morris, RE ;
Chen, H ;
Sadler, PJ ;
Jodrell, DI .
BRITISH JOURNAL OF CANCER, 2002, 86 (10) :1652-1657
[3]   The discovery and development of cisplatin [J].
Alderden, RA ;
Hall, MD ;
Hambley, TW .
JOURNAL OF CHEMICAL EDUCATION, 2006, 83 (05) :728-734
[4]   Symmetrical dinuclear complexes with high DNA affinity based on [Ru(dpq)2(phen)]2+ [J].
Aldrich-Wright, J ;
Brodie, C ;
Glazer, EC ;
Luedtke, NW ;
Elson-Schwab, L ;
Tor, Y .
CHEMICAL COMMUNICATIONS, 2004, (08) :1018-1019
[5]  
Aldrich-Wright J.R., 2002, DALTON T, P4666
[6]   Design of chiral picen-based metal complexes for molecular recognition of α-aminoacids and nucleic acids [J].
Aldrich-Wright, JR ;
Vagg, RS ;
Williams, PA .
COORDINATION CHEMISTRY REVIEWS, 1997, 166 :361-389
[7]   Ruthenium antimetastatic agents [J].
Alessio, E ;
Mestroni, G ;
Bergamo, A ;
Sava, G .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (15) :1525-1535
[8]   Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance [J].
Ang, WH ;
Khalaila, I ;
Allardyce, CS ;
Juillerat-Jeanneret, L ;
Dyson, PJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (05) :1382-1383
[9]   INVIVO INHIBITION OF TUMOR-GROWTH BY RUTHENIUM RED - ITS RELATIONSHIP WITH METABOLISM OF CALCIUM IN TUMOR [J].
ANGHILERI, LJ .
ZEITSCHRIFT FUR KREBSFORSCHUNG UND KLINISCHE ONKOLOGIE, 1975, 83 (03) :213-217
[10]   Ruthenium-based chemotherapeutics: are they ready for prime time? [J].
Antonarakis, Emmanuel S. ;
Emadi, Ashkan .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (01) :1-9